Kammoun, A.K.; Hegazy, M.A.; Khedr, A.; Awan, Z.A.; Khayat, M.T.; Al-Sawahli, M.M.
Correction: Kammoun et al. Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells. Pharmaceuticals 2022, 15, 916. Pharmaceuticals 2025, 18, 505.
https://doi.org/10.3390/ph18040505
AMA Style
Kammoun AK, Hegazy MA, Khedr A, Awan ZA, Khayat MT, Al-Sawahli MM.
Correction: Kammoun et al. Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells. Pharmaceuticals 2022, 15, 916. Pharmaceuticals. 2025; 18(4):505.
https://doi.org/10.3390/ph18040505
Chicago/Turabian Style
Kammoun, Ahmed K., Maha A. Hegazy, Alaa Khedr, Zuhier Ahmed Awan, Maan T. Khayat, and Majid Mohammad Al-Sawahli.
2025. "Correction: Kammoun et al. Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells. Pharmaceuticals 2022, 15, 916" Pharmaceuticals 18, no. 4: 505.
https://doi.org/10.3390/ph18040505
APA Style
Kammoun, A. K., Hegazy, M. A., Khedr, A., Awan, Z. A., Khayat, M. T., & Al-Sawahli, M. M.
(2025). Correction: Kammoun et al. Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells. Pharmaceuticals 2022, 15, 916. Pharmaceuticals, 18(4), 505.
https://doi.org/10.3390/ph18040505
